Back to Agendas
PMDA Town Hall
Session Chair(s)
Toshiyoshi Tominaga, PhD
Life Science Department, Advisor, Sunflare, Japan
Representatives from PMDA will explain the progress of its third Five-Year Mid-Term plan, including the future initiative/challenges for faster review and better life cycle management of drugs. The audience will be provided an opportunity to ask questions to the panel.
Learning Objective : Recognize the latest progress of PMDA and Japanese regulation; Discuss with PMDA senior officials Japanese regulatory issues.
Speaker(s)
New Regulation in Japan and Future Direction of PMDA
Tatsuya Kondo, MD, PhD
President, SH Medical Excellence JAPAN, Japan
Science-based Initiatives of PMDA
Takao Yamori
Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
New Streams of Risk Management
Tomiko Tawaragi
Director, RAD-AR Council, Japan
PMD Act and SAKIGAKE Strategy
Nobumasa Nakashima
Professor / Director, Department of Medicinal Regulatory Science, Graduate Schoo, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan
Have an account?